Application of Super-Resolution Ultrasound Contrast Imaging in Differentiating Benign From Malignant Breast Tumors
- 30 May 2026
- journal article
- research article
- Published by SAGE Publications in Ultrasonic Imaging
Abstract
This study evaluated the utility of super-resolution ultrasound contrast imaging for differentiating benign from malignant breast tumors. In this retrospective study, 60 patients underwent contrast-enhanced ultrasound acquisition before biopsy or surgery excision at The Third Affiliated Hospital of Nanjing Medical University between March and November 2025. Super-resolution contrast-enhanced ultrasound (SRUS) reconstruction and quantitative analysis were then performed from contrast-enhanced ultrasound cine loops using microbubble localization and tracking software. Using histopathology as the reference standard, patients were classified into malignant and benign groups. The discriminatory value of each parameter for benign versus malignant breast tumors was assessed. Diagnostic performance was quantified using the area under the receiver operating characteristic curve (AUC). The diagnostic performance of each SRUS-derived parameter was evaluated for differentiating benign from malignant breast tumors. On final pathology, SRUS-derived parameters showed good performance for differentiating benign from malignant breast tumors. Compared with benign lesions, malignant tumors exhibited significantly higher FD, number of branching points per area maximum curvature, mean curvature, maximum vessel velocity, mean vessel velocity, maximum diameter, mean diameter, and microvasculature density (all p < .050). Among all parameters, maximum curvature achieved the highest AUC (0.933), with 88.0% sensitivity and 80.0% specificity. Intra- and inter-operator reliability were high, with intraclass correlation coefficients >.85. SRUS-derived quantitative parameters showed diagnostic value for differentiating benign from malignant breast masses and enable clear visualization of hemodynamic alterations, suggesting potential value for preoperative malignant-risk assessment.Keywords
Funding Information
- Jiangsu Provincial Medical Key Discipline Construction Unit (Oncology Therapeutics (No. JSDW202237)
- National Natural Science Foundation of China (No. 62371243)
- Social Development Project of Jiangsu Provincial Key Research & Development Plan (No. BE2022720)
This publication has 45 references indexed in Scilit:
- Quantitative angiogenesis-based ultrasound biomarkers for differentiating radiologically challenging breast lesions: Radial scar vs invasive ductal carcinomaThe Breast, 2025
- Meta‐analysis of contrast‐enhanced ultrasound in differential diagnosis of breast adenosis and breast cancerJournal of Clinical Ultrasound, 2024
- Novel insights into DNA methylation-based epigenetic regulation of breast tumor angiogenesis2023
- Superb Microvascular Imaging for the Differentiation of Benign and Malignant Breast Lesions: A System Review and Meta‐AnalysisJournal of Ultrasound in Medicine, 2022
- Ultrasound high-definition microvasculature imaging with novel quantitative biomarkers improves breast cancer detection accuracyEuropean Radiology, 2022
- A Review of Clinical Applications for Super-resolution Ultrasound Localization MicroscopyCurrent Medical Science, 2022
- Clinical Applications of Superb Microvascular Imaging in the Superficial Tissues and Organs: A Systematic ReviewAcademic Radiology, 2021
- Role of Superb Microvascular Imaging in Differentiating Between Malignant and Benign Solid Breast MassesClinical Breast Cancer, 2020
- Tumor angiogenesis: causes, consequences, challenges and opportunitiesCellular and Molecular Life Sciences, 2019
- Correlative Multiscale 3D Imaging of a Hierarchical Nanoporous Gold Catalyst by Electron, Ion and X‐ray NanotomographyChemCatChem, 2018